Denmark
· Delayed Price · Currency is DKK Brain+ Company Description
Brain+ A/S develops digital therapeutics for Alzheimer’s and dementia.
It develops cognitive stimulation therapy (CST)-Assistant, a health tech solution to support scalable and delivery of group CST via a readily accessible preparation system, content adaptability and a standardized delivery form, which lessens the dependence of CST performance on therapists; CST - Home Care for use to extend and scale the delivery of CST to a home setting, enabling broader access to the therapy for a dementia population at limited costs; CST/ computerized cognitive training (CCT) combination product for individuals with mild cognitive impairment, combining cognitive stimulation therapy with computerized cognitive training to train cognitive function and potentially delay the transition to dementia; and Starry Night, a software based test designed to detect early signs of cognitive decline and enable early targeted intervention and treatment.
Brain+ A/S was incorporated in 2012 and is based in Copenhagen, Denmark.
| Country | Denmark |
| Founded | 2012 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 20 |
| CEO | Kim Baden-Kristensen |
Contact Details
Address: Købmagergade 53 Copenhagen, 1150 Denmark | |
| Website | brain-plus.com |
Stock Details
| Ticker Symbol | BRAINP |
| Exchange | Copenhagen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | DKK |
| ISIN Number | DK0061670205 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Kim Baden-Kristensen | Founder, Chief Executive Officer and MD |
| Rasmus Højengaard | Founder and CCO |
| Hanne Leth Hillman M.Sc. | Interim Chief Financial Officer |
| Paula Petcu | Chief Technology Officer |
| Simon Nielsen | Chief Science and Innovation Officer |
| Bjarke Langbol Panduro | Marketing and Product Manager |
| Bertil Stengaard Jessen | Chief Financial Officer (Leave of Absence) |